These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 2013615

  • 1. Active production of anti-human T-lymphotropic virus type I (HTLV-I) IgM antibody in HTLV-I-associated myelopathy.
    Nagasato K, Nakamura T, Ohishi K, Shibayama K, Motomura M, Ichinose K, Tsujihata M, Nagataki S.
    J Neuroimmunol; 1991 May; 32(2):105-9. PubMed ID: 2013615
    [Abstract] [Full Text] [Related]

  • 2. Presence of serum anti-human T-lymphotropic virus type I (HTLV-I) IgM antibodies means persistent active replication of HTLV-I in HTLV-I-associated myelopathy.
    Nagasato K, Nakamura T, Shirabe S, Shibayama K, Ohishi K, Ichinose K, Tsujihata M, Nagataki S.
    J Neurol Sci; 1991 Jun; 103(2):203-8. PubMed ID: 1880539
    [Abstract] [Full Text] [Related]

  • 3. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection.
    Kubota R, Kawanishi T, Matsubara H, Manns A, Jacobson S.
    J Immunol; 1998 Jul 01; 161(1):482-8. PubMed ID: 9647259
    [Abstract] [Full Text] [Related]

  • 4. Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy.
    Kitze B, Usuku K, Izumo S, Nakamura M, Shiraki H, Ijichi S, Yashiki S, Fujiyoshi T, Sonoda S, Osame M.
    J Neurol; 1996 May 01; 243(5):393-400. PubMed ID: 8741079
    [Abstract] [Full Text] [Related]

  • 5. Standardisation of Western blotting to detect HTLV-1 antibodies synthesised in the central nervous system of HAM/TSP patients.
    Ribeiro LC, Gonçalves CC, Slater CM, Carvalho SM, Puccioni-Sohler M.
    Mem Inst Oswaldo Cruz; 2013 Sep 01; 108(6):730-4. PubMed ID: 24037195
    [Abstract] [Full Text] [Related]

  • 6. Viral-specific humoral immune responses following transfusion-related transmission of human T cell lymphotropic virus type-I infection.
    Manns A, Wilks RJ, Hanchard B, Morgan OS, Rudolph DL, Lal RB.
    Viral Immunol; 1994 Sep 01; 7(3):113-20. PubMed ID: 7598784
    [Abstract] [Full Text] [Related]

  • 7. Human T lymphotropic virus type I (HTLV-I) proviral load in cerebrospinal fluid: a new criterion for the diagnosis of HTLV-I-associated myelopathy/tropical spastic paraparesis?
    Lezin A, Olindo S, Oliere S, Varrin-Doyer M, Marlin R, Cabre P, Smadja D, Cesaire R.
    J Infect Dis; 2005 Jun 01; 191(11):1830-4. PubMed ID: 15871115
    [Abstract] [Full Text] [Related]

  • 8. Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Burbelo PD, Meoli E, Leahy HP, Graham J, Yao K, Oh U, Janik JE, Mahieux R, Kashanchi F, Iadarola MJ, Jacobson S.
    Retrovirology; 2008 Oct 20; 5():96. PubMed ID: 18937847
    [Abstract] [Full Text] [Related]

  • 9. Human T-lymphotropic virus type I (HTLV-I)-specific antibodies and cell-free RNA in crevicular fluid-rich saliva from patients with tropical spastic paraparesis/HTLV-I-associated myelopathy.
    Soto-Ramirez LE, Garcia-Vallejo F, Renjifo B, Vergara A, Borrero I, Marlink R, Essex M.
    Viral Immunol; 1995 Oct 20; 8(3):141-50. PubMed ID: 8833267
    [Abstract] [Full Text] [Related]

  • 10. Modulation of T cell responses in HTLV-1 carriers and in patients with myelopathy associated with HTLV-1.
    Santos SB, Porto AF, Muniz AL, Luna T, Nascimento MC, Guerreiro JB, Oliveira-Filho J, Morgan DJ, Carvalho EM.
    Neuroimmunomodulation; 2006 Oct 20; 13(3):145-51. PubMed ID: 17119343
    [Abstract] [Full Text] [Related]

  • 11. Anti-Tax antibody levels in asymptomatic carriers, oligosymptomatic carriers, patients with rheumatologic disease or with HAM/TSP do not correlate with HTLV-1 proviral load.
    de Souza JG, da Fonseca FG, Martins ML, Martins CP, de Carvalho LD, Coelho-dos-Reis JG, Carneiro-Proietti AB, Martins-Filho OA, Barbosa-Stancioli EF, GIPH.
    J Clin Virol; 2011 Jan 20; 50(1):13-8. PubMed ID: 20951636
    [Abstract] [Full Text] [Related]

  • 12. Antibody-dependent cell-mediated cytotoxicity (ADCC) in HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Fujihara K, Itoyama Y, Yu F, Kubo C, Goto I.
    J Neurol Sci; 1996 Oct 20; 142(1-2):65-9. PubMed ID: 8902722
    [Abstract] [Full Text] [Related]

  • 13. Tissue inhibitor of metalloproteinase 3, matrix metalloproteinase 9, and neopterin in the cerebrospinal fluid: preferential presence in HTLV type I-infected neurologic patients versus healthy virus carriers.
    Lezin A, Buart S, Smadja D, Akaoka H, Bourdonné O, Perret-Liaudet A, Césaire R, Belin MF, Giraudon P.
    AIDS Res Hum Retroviruses; 2000 Jul 01; 16(10):965-72. PubMed ID: 10890358
    [Abstract] [Full Text] [Related]

  • 14. Increased human T lymphotropic virus type-1 (HTLV-1) proviral DNA in peripheral blood mononuclear cells and bronchoalveolar lavage cells from Japanese patients with HTLV-1-associated myelopathy.
    Mita S, Sugimoto M, Nakamura M, Murakami T, Tokunaga M, Uyama E, Araki S.
    Am J Trop Med Hyg; 1993 Feb 01; 48(2):170-7. PubMed ID: 8447519
    [Abstract] [Full Text] [Related]

  • 15. Clinical and laboratory features of HTLV-I asymptomatic carriers and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis from the Brazilian Amazon.
    Takatani M, Crispim ME, Fraiji N, Stefani MM, Kiesslich D.
    Rev Inst Med Trop Sao Paulo; 2017 Apr 03; 59():e5. PubMed ID: 28380116
    [Abstract] [Full Text] [Related]

  • 16. Elevated antibodies to synthetic peptides of HTLV-1 envelope transmembrane glycoproteins in patients with HAM/TSP.
    Nakamura M, Kuroki M, Kira J, Itoyama Y, Shiraki H, Kuroda N, Washitani Y, Nakano S, Nagafuchi S, Anzai K.
    J Neuroimmunol; 1991 Dec 03; 35(1-3):167-77. PubMed ID: 1955565
    [Abstract] [Full Text] [Related]

  • 17. High IFN-γ/IL-10 expression ratio and increased frequency of persistent human T-cell lymphotropic virus type 1-infected clones are associated with human T-cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis development.
    Espíndola OM, Oliveira LC, Ferreira PM, Leite AC, Lima MA, Andrada-Serpa MJ.
    Intervirology; 2015 Dec 03; 58(2):106-14. PubMed ID: 25833232
    [Abstract] [Full Text] [Related]

  • 18. Infective dermatitis and human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in childhood and adolescence.
    Primo JR, Brites C, Oliveira Mde F, Moreno-Carvalho O, Machado M, Bittencourt AL.
    Clin Infect Dis; 2005 Aug 15; 41(4):535-41. PubMed ID: 16028164
    [Abstract] [Full Text] [Related]

  • 19. Levels of serum chemokines discriminate clinical myelopathy associated with human T lymphotropic virus type 1 (HTLV-1)/tropical spastic paraparesis (HAM/TSP) disease from HTLV-1 carrier state.
    Guerreiro JB, Santos SB, Morgan DJ, Porto AF, Muniz AL, Ho JL, Teixeira AL, Teixeira MM, Carvalho EM.
    Clin Exp Immunol; 2006 Aug 15; 145(2):296-301. PubMed ID: 16879249
    [Abstract] [Full Text] [Related]

  • 20. Different B-cell responses to human T-cell lymphotropic virus type I (HTLV-I) envelope synthetic peptides in HTLV-I-infected individuals.
    Ida H, Kurata A, Eguchi K, Kawakami A, Migita K, Fukuda T, Nakamura T, Kusumoto Y, Berzofsky JA, Nagataki S.
    J Clin Immunol; 1991 May 15; 11(3):143-51. PubMed ID: 1890164
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.